Alkermes plc logo

Alkermes plc

NASDAQ:ALKS

Overview | Financials
Company Name Alkermes plc
Symbol ALKS
Currency USD
Price 27.03
Market Cap 4,457,274,030
Dividend Yield 0%
52-week-range 24.48 - 36.45
Industry Biotechnology
Sector Healthcare
CEO Mr. Richard F. Pops
Website https://www.alkermes.com

An error occurred while fetching data.

About Alkermes plc

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; VIVITROL for the treatment of alcohol and

Related Stocks

Evotec SE logo

Evotec SE

EVO

8.69 USD

Premier, Inc. logo

Premier, Inc.

PINC

21.11 USD

Lantheus Holdings, Inc. logo

Lantheus Holdings, Inc.

LNTH

72.34 USD

Medpace Holdings, Inc. logo

Medpace Holdings, Inc.

MEDP

477.73 USD

Omnicell, Inc. logo

Omnicell, Inc.

OMCL

28.26 USD

The Ensign Group, Inc. logo

The Ensign Group, Inc.

ENSG

136.36 USD

Apellis Pharmaceuticals, Inc. logo

Apellis Pharmaceuticals, Inc.

APLS

19.89 USD

Tandem Diabetes Care, Inc. logo

Tandem Diabetes Care, Inc.

TNDM

15.31 USD

ICU Medical, Inc. logo

ICU Medical, Inc.

ICUI

126.24 USD

Financials

Numbers are in millions USD

Numbers are in millions USD